Relationship between machine-derived smoke yields and biomarkers in cigarette smokers in Germany

Regulatory Toxicology and Pharmacology

Volumn 47, Issue 2, 2007, Pages 171-183

  Scherer, Gerhard ^a   Engl, Johannes ^a   Urban, Michael ^a   Gilch, Gerhard ^a   Janket, Dinamis ^a   Riedel, Kirsten ^a  

^a Analytisch Biologisches Forschungslabor GmbH   (Germany)

Author keywords

Biomarkers of exposure; ISO smoking conditions; Nicotine yields; Tar yields

Indexed keywords

1 HYDROXYPYRENE; 3 HYDROXYPROPYLMERCAPTURIC ACID; 3' HYDROXYCOTININE; 4 (METHYLNITROSAMINO) 1 (3 PYRIDYL) 1 BUTANOL; ACROLEIN; ACRYLAMIDE; BENZENE; BIOLOGICAL MARKER; CARBAMOYLETHYLVALINE; CARBON MONOXIDE; COTININE; GLUCURONIDE; HEMOGLOBIN A; MUCONIC ACID; NICOTINE; NITROSAMINE 4 (METHYLNITROSAMINO) 1 (3 PYRIDYL) 1 BUTANONE; PYRENE; S PHENYLMERCAPTOPURIC ACID; TAR; UNCLASSIFIED DRUG; VALINE;

ADULT; ARTICLE; CIGARETTE SMOKING; CONTROLLED STUDY; EXPIRED AIR; EXPOSURE; FEMALE; GERMANY; HUMAN; HUMAN EXPERIMENT; MALE; METABOLITE; PRIORITY JOURNAL; SALIVA;

ADOLESCENT; ADULT; AUTOMATION; BIOLOGICAL MARKERS; ENVIRONMENTAL EXPOSURE; FEMALE; GERMANY; HUMANS; MALE; MIDDLE AGED; NICOTINE; REPRODUCIBILITY OF RESULTS; SALIVA; SMOKE; SMOKING; TARS; TOBACCO; URINALYSIS;

NICOTIANA TABACUM;

EID: 33846781400     PISSN: 02732300     EISSN: 10960295     Source Type: Journal    
DOI: 10.1016/j.yrtph.2006.09.001     Document Type: Article

References (95)

1. Augustine A., Harris R.E., and Wynder E.L. Compensation as a risk factor for lung cancer in smokers who switch from nonfilter to filter cigarettes. American Journal of Public Health 79 (1989) 188-190
2. Bader M., Lewalter J., and Angerer J. Analysis of N-alkylated amino acids in human hemoglobin: evidence for elevated N-methylvaline levels in smokers. International Archives of Occupational and Environmental Health 67 (1995) 237-242
3. Benowitz N.L. The human pharmacology of nicotine. In: Cappell H.D. (Ed). Research Advances in Alcohol and Drug Problems (1986), Plenum Press, New York 1-52
4. Benowitz N.L. Pharmacokinetics and pharmacodynamics of nicotine. In: Rand M.J., and Thurau K. (Eds). The Pharmacology of Nicotine (1987), IRL Press, Oxford, Washington, DC 3-18
5. Benowitz N.L. Cotinine as a biomarker of environmental tobacco smoke exposure. Epidemiology Reviews 18 (1996) 188-204
6. Benowitz, N.L. 2001. Compensatory smoking of low-yield cigarettes. In: Public Health Services, National Institutes of Health, National Cancer Institute (Eds.) Smoking and Tobacco Control. Risks Associated with Smoking Cigarettes with Low Machine-Measured Yields of Tar and Nicotine, NIH Publication, Bethesda, MD, USA, pp. 39-63.
7. Benowitz N.L., Jacob III P., Bernert J.T., Wilson M., Wang L., Allen F., and Dempsey D. Carcinogen exposure during short-term switching from regular to "light" cigarettes. Cancer Epidemiology, Biomarkers & Prevention 14 (2005) 1376-1383
8. Bergmark E. Hemoglobin adducts of acrylamide and acrylonitrile in laboratory workers, smokers, and nonsmokers. Chemical Research in Toxicology 10 (1997) 78-84
9. Bernert J.T., Jain R.B., Pirkle J.L., Wang L., Miller B.B., and Sampson E.J. Urinary tobacco-specific nitrosamines and 4-aminobiphenyl hemoglobin adducts measured in smokers of either regular or light cigarettes. Nicotine & Tobacco Research 7 (2005) 729-738
10. Binder, H., Lindner, W., 1972. Bestimmung von Äthylenoxid im Rauch garantiert unbegaster Zigaretten. Fachliche Mitteilungen der Austria Tabakwerke AG 13, 215-220.
11. Bono R., Vincenti M., Meineri V., Pignata C., Saglia U., Giachino O., and Scursatone E. Formation of N-(2-hydroxyethyl)valine due to exposure to ethylene oxide via tobacco smoke: a risk factor for onset of cancer. Environmental Research 81 (1999) 62-71
12. Boogaard P.J., and van Sittert N.J. Biological monitoring of exposure to benzene: a comparison between S-phenylmercapturic acid, trans,trans-muconic acid, and phenol. Occupational and Environmental Medicine 52 (1995) 611-620
13. Boogaard P.J., and van Sittert N.J. Suitability of S-phenyl mercapturic acid and trans,trans-muconic acid as biomarkers for exposure to low concentrations of benzene. Environmental Health Perspectives 104 (1996) 1151-1157
14. Byrd G.D., Davis R.A., Caldwell W.S., Robinson J.H., and deBethizy J.D. A further study of FTC yield and nicotine absorption in smokers. Psychopharmacology 134 (1997) 291-299
15. Byrd G.D., Davis R.A., Caldwell W.S., Robinson J.H., and deBethizy J.D. A further study of FTC yield and nicotine absorption in smokers. Psychopharmacology 139 (1998) 291-299
16. Curvall M., Kazemi-Vala E., and Englund G. Conjugation pathways in nicotine metabolism. In: Adlkofer F., and Thurau K. (Eds). Effects of Nicotine on Biological Systems (1991), Birkhäuser Verlag, Basel 69-75
17. Dor F., Dab W., Empereur-Bissonnet P., and Zmirou D. Validity of biomarkers in environmental health studies: the case of PAHs and benzene. Critical Reviews in Toxicology 29 (1999) 129-168
18. Dybing E., Farmer P.B., Andersen M., Fennell T.R., Lalljie S.P., Muller D.J., Olin S., Petersen B.J., Schlatter J., Scholz G., Scimeca J.A., Slimani N., Tornqvist M., Tuijtelaars S., and Verger P. Human exposure and internal dose assessments of acrylamide in food. Food Chem.Toxicol. 43 (2005) 365-410
19. Etzel R.A. A review of the use of Saliva cotinine as a marker of tobacco smoke exposure. Preventive Medicine 19 (1990) 190-197
20. Fagerström K.O., and Bates S. Compensation and effective smoking by different nicotine dependent smokers. Addictive Behaviors 6 (1981) 331-336
21. Farmer P.B., Cordero R., and Autrup H. Monitoring human exposure to 2-hydroxyethylating carcinogens. Environmental Health Perspectives 104 (1996) 449-452
22. Feng S., Roethig H.J., Liang Q., Kinser R., Jin Y., Scherer G., Urban M., Engl J., and Riedel K. Evaluation of urinary 1-hydroxypyrene, S-phenylmercapturic acid, trans,trans-muconic acid, 3-methyladenine, 3-ethyladenine, 8-hydroxy-2′-deoxyguanosine and thioethers as biomarkers of exposure to cigarette smoke. Biomarkers 11 (2006) 28-52
23. Fennell T.R., MacNeela J.P., Morris R.W., Watson M., Thompson C.L., and Bell D.A. Hemoglobin adducts from acrylonitrile and ethylene oxide in cigarette smokers: effects of glutathione S-transferase T1-null and M1-null genotypes. Cancer Epidemiology, Biomarkers & Prevention 9 (2000) 705-712
24. Fortmann S.P., Rogers T., Vranizan K., Haskell W.L., Solomon D.S., and Farquhar J.W. Indirect measures of cigarette use: expired-air carbon monoxide versus plasma thiocyanate. Preventive Medicine 13 (1984) 127-135
25. Ghittori, S., Maestri, L., and Imbriani, M. 1993. The role of urinary S-phenylmercapturic acid (S-PMA) as indicator of exposure to benzene in smokers and non-smokers in urban environment. In: Jaakkola, J.J.K., Ilmarinen, R., Seppänen, O. (Eds.) Health Effects. Gummerus Oy, Jyväskylä, Finland, Helsinki, pp. 681-686.
26. Grimmer G., Naujack K.W., and Dettbarn G. Gaschromatographic determination of polycyclic aromatic hydrocarbons, aza-arenes, aromatic amines in the particle and vapor phase of mainstream and sidestream smoke of cigarettes. Toxicology Letters 35 (1987) 117-124
27. Guerin M.R., Jenkins R.A., and Tomkins B.A. The Chemistry of Environmental Tobacco Smoke: Composition and Measurement (1992), Lewis Publishers, Boca Raton, Ann Arbor, London, Tokyo
28. Haley N.J., Sepkovic W., Hoffmann D., and Wynder E.L. Cigarette smoking as a risk for cardiovascular disease. Part VI. Compensation with nicotine availability as a single variable. Clinical Pharmacology and Therapeutics 38 (1985) 164-170
29. Hammond D., Fong G.T., Cummings K.M., O'Connor R.J., Giovino G.A., and McNeill A. Cigarette yields and human exposure: a comparison of alternative testing regimens. Cancer Epidemiology, Biomarkers & Prevention 15 (2006) 1495-1501
30. Hecht S.S. Human urinary carcinogen metabolites: biomarkers for investigating tobacco and cancer. Carcinogenesis 23 (2002) 907-922
31. Hecht S.S., Murphy S.E., Carmella S.G., Li S., Jensen J., Le C., Joseph A.M., and Hatsukami D.K. Similar uptake of lung carcinogens by smokers of regular, light, and ultralight cigarettes. Cancer Epidemiology, Biomarkers & Prevention 14 (2005) 693-698
32. Heinemann G., Schievelbein H., and Richter F. Die analytische und diagnostische Validität der Bestimmung von Carboxyhämoglobin im Blut und Kohlenmonoxid in der Atemluft von Rauchern und Nichtrauchern. Journal of Clinical Chemistry and Clinical Biochemistry 22 (1984) 229-235
33. Henningfield J.E., Burns D.M., and Dybing E. Guidance for research and testing to reduce tobacco toxicant exposure. Nicotine & Tobacco Research 7 (2005) 821-826
34. Heudorf U., and Angerer J. Urinary monohydroxylated phenanthrenes and hydroxypyrene-the effects of smoking habits and changes induced by smoking on monooxygenase-mediated metabolism. International Archives of Occupational and Environmental Health 74 (2001) 177-183
35. Hoffmann D., Hoffmann I., and El Bayoumy K. The less harmful cigarette: a controversial issue. A tribute to Ernst L. Wynder. Chemical Research in Toxicology 14 (2001) 767-790
36. Institute of Medicine, 2001. Clearing the Smoke: Assessing the Science Base for Tobacco Harm Reduction, National Academy Press, Washington, DC.
37. International Agency for Research on Cancer, 1986. Tobacco Smoking. IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans, IARC, Lyon.
38. International Agency for Research on Cancer, 2004. Tobacco smoke and involuntary smoking. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans 83, pp. 1-1438.
39. International Standard Organisation (ISO) (1991) ISO 4387: Cigarettes; Determination of total and nicotine free dry particulate matter using a routine analytical smoking machine.
40. Jarvis M.J., Belcher M., Vesey C., and Hutchison D.C.S. Low cost carbon monoxide monitors in smoking assessment. Thorax 41 (1986) 886-887
41. Jarvis M.J., Boreham R., Primatesta P., Feyerabend C., and Bryant A. Nicotine yield from machine-smoked cigarettes and nicotine intake in smokers: evidence from a representative population survey. Journal of the National Cancer Institute 93 (2001) 134-138
42. Jongeneelen F., and Anzion R.B.M. 1-Hydroxypyrene. In: Angerer J. (Ed). Analyses of Hazardous Substances in Biological Materials (1990), VCH Verlagsgesellschaft mbH, Weinheim 151-169
43. Jongeneelen F.J., Anzion R.B.M., Leijdekkers C.M., Bos R.P., and Henderson P.T. 1-Hydroxypyrene in human urine after exposure to coal tar and a coal tar derived product. International Archives of Occupational and Environmental Health 57 (1985) 47-55
44. Kaye C.M. Biosynthesis of mercapturic acids from allyl alcohol, allyl ester and acrolein. Journal of Biochemistry 134 (1973) 1093-1101
45. Kim I., Wtsadik A., Choo R.E., Jones H.E., and Huestis M.A. Usefulness of salivary trans-3′-hydroxycotinine concentration and trans-3′-hydroxycotinine/cotinine ratio as biomarkers of cigarette smoke in pregnant women. Journal of Analytical Toxicology 29 (2005) 689-695
46. Lando H.A., McGovern P.G., Kelder S.H., Jeffery R.W., and Forster J.L. Use of carbon monoxide breath validation in assessing exposure to cigarette smoke in a worksite population. Health Psychology 10 (1991) 296-301
47. Lee P.N. Uses and abuses of cotinine as a marker of tobacco smoke exposure. In: Gorrod J.W. (Ed). Nicotine and related compounds and their metabolites (1999), Elsevier, Amsterdam 669-719
48. Lee P.N. Lung cancer and type of cigarette smoked. Inhalation Toxicology 13 (2001) 951-976
49. Leonard A., Gerber G.B., Stecca C., Rueff J., Borba H., Farmer P.B., Sram R.J., Czeizel A.E., and Kalina I. Mutagenicity, carcinogenicity, and teratogenicity of acrylonitrile. Mutation Research 436 (1999) 263-283
50. Lewalter J. N-alkylvaline levels in globin as a new type of biomarker in risk assessment of alkylating agents. International Archives of Occupational and Environmental Health 68 (1996) 519-530
51. Martin J.E., Prue D.M., Collins F.L.j., and Thames C.J. The effects of graduated filters on smoking exposure: risk reduction or compensation?. Addictive Behaviors 6 (1981) 167-176
52. Mascher D.G., Mascher H.J., Scherer G., and Schmid E.R. High-performance liquid chromatographic-tandem mass spectrometric determination of 3-hydroxypropylmercapturic acid in human urine. Journal of Chromatography B: Biomedical Sciences and Applications 750 (2001) 163-169
53. Medeiros A.M., Bird M.G., and Witz G. Potential biomarkers of benzene exposure. Journal of Toxicology and Environmental Health 51 (1997) 519-539
54. Meger M., Meger-Kossien I., Schuler-Metz A., Janket D., and Scherer G. Simultaneous determination of nicotine and eight nicotine metabolites in urine of smokers using liquid chromatography tandem mass spectrometric (LC-MSMS) detection. Journal of Chromatography B 778 (2002) 251-261
55. Milikian A.A., O'Connor R., Prahalad A.K., Hu P., Li H., Kagan M., and Thompson S. Determination of the urinary benzene metabolites S-phenylmercapturic acid and trans,trans-muconic acid by liquid chromatography-tandem mass spectrometry. Carcinogenesis 20 (1999) 719-726
56. Müller M., Krämer A., Angerer J., and Hallier E. Ethylene oxide-protein adduct formation in humans: influence of glutathione-S-transferase polymorphisms. International Archives of Occupational and Environmental Health 71 (1998) 499-502
57. Nakazawa A., Shigeta M., and Ozasa K. Smoking cigarettes of low nicotine yield does not reduce nicotine intake as expected: a study of nicotine dependency in Japanese males. BMC.Public Health 4 (2004) 28
58. Neurath G.B., Dünger M., Orth D., and Pein F.G. Trans-3′-hydroxycotinine as a main metabolite in urine of smokers. International Archives of Occupational and Environmental Health 59 (1987) 199-201
59. Phillips D.H. Smoking-related DNA and protein adducts in human tissues. Carcinogenesis 23 (2002) 1979-2004
60. Pritchard W.S., and Robinson J.H. Examining the relation between usual-brand nicotine yield, blood cotinine concentration, and the nicotine-"compensation" hypothesis. Psychopharmacology 124 (1996) 282-284
61. Renner T., Baer-Koetzle M., and Scherer G. Determination of sorbic acid in urine by gas chromatography-mass spectrometry. Journal of Chromatography A 847 (1999) 127-133
62. Roethig H.J., Kinser R.D., Lau R.W., Walk R.A., and Wang N. Short-term exposure evaluation of adult smokers switching from conventional to first-generation electrically heated cigarettes during controlled smoking. Journal of Clinical Pharmacology 45 (2005) 133-145
63. Ruppert T., Scherer G., Tricker A.R., Rauscher D., and Adlkofer F. Determination of urinary trans,trans-muconic acid by gas chromatography-mass spectrometry. Journal of Chromatography 666 (1995) 71-76
64. Russell M.A.H. Nicotine intake and its control over smoking. In: Wonnacott S. (Ed). Nicotine Psychopharmacology (1990), Oxford University Press, Oxford, New York, Tokyo 374-418
65. Scherer G. Smoking behaviour and compensation: a review of the literature. Psychopharmacology 145 (1999) 1-20
66. Scherer G. Biomonitoring of inhaled complex mixtures-ambient air, diesel exhaust and cigarette smoke. Experimental and Toxicologic Pathology 57 (2005) 75-110
67. Scherer G., Conze C., Tricker A.R., and Adlkofer F. Uptake of tobacco smoke constituents on exposure to environmental tobacco smoke (ETS). The Clinical Investigator 70 (1992) 352-367
68. Scherer G., Frank S., Riedel K., Meger-Kossien I., and Renner T. Biomonitoring of exposure to polycyclic aromatic hydrocarbons of nonoccupationally exposed persons. Cancer Epidemiology, Biomarkers & Prevention 9 (2000) 373-380
69. Scherer, G., Krause, G., Mascher, D., and Schmid, E. (2000b) Biological monitoring of the tobacco smoke-related exposure to acrolein. Proceedings of the American Association for Cancer Research. 91st Annual meeting, April 1-5, 2000, San Francisco.
70. Scherer G., Meger M., Meger-Kossien I., and Pachinger A. Biological monitoring of the tobacco smoke-related exposure to benzene. Proceedings of the American Association for Cancer Research 42 (2001) 150
71. Scherer G., Renner T., and Meger M. Analysis and evaluation of trans,trans-muconic acid as a biomarker for benzene exposure. Journal of Chromatography 717 (1998) 179-199
72. Scherer G., Urban M., and Meger M. Biological monitoring of the tobacco smoke-related exposure to alkylating agents. Proceedings of the American Association for Cancer Research 42 (2001) 149-150
73. Schettgen T., Broding H., Angerer J., and Drexler H. Hemoglobin adducts of ethylene oxide, propylene oxide, acrylonitrile and acrylamide-biomarkers in occupational and environmental medicine. Toxicology Letters 134 (2002) 65
74. Shields P.G. Tobacco smoking, harm reduction, and biomarkers. Journal of the National Cancer Institute 94 (2002) 1435-1444
75. Sithisarankul P., Vineis P., Kang D., Rothman N., Caporaso N., and Strickland P. Association of 1-hydroxypyrene-glucuronide in human urine with cigarette smoking and broiled or roasted meat consumption. Biomarkers 2 (1997) 217-221
76. Smith C.J., Perfetti T.A., Rumple M.A., Rodgman A., and Doolittle D.J. "IARC group 2A carcinogens" reported in cigarette mainstream smoke. Food and Chemical Toxicology 38 (2000) 371-383
77. Tareke E., Rydberg P., Karlsson P., Eriksson S., and Tornqvist M. Analysis of acrylamide, a carcinogen formed in heated foodstuffs. Journal of Agricultural and Food Chemistry 50 (2002) 4998-5006
78. Tareke E., Rydberg P., Karlsson P., Eriksson S., and Törnqvist M. Acrylamide: a cooking carcinogen?. Chemical Research in Toxicology 13 (2000) 517-522
79. Tavares R., Borba H., Monteiro M., Proença M.J., Lynce N., Rueff J., Bailey E., Sweetman G.M.A., Lawrence R.M., and Farmer P.B. Monitoring of exposure to acrylonitrile by determination of N-(2-cyanoethyl)valine at the N-terminal position of haemoglobin. Carcinogenesis 17 (1996) 2655-2660
80. Tavares R., Ramos P., Palminha J., Bispo M.A., Paz I., Bras A., Rueff J., Farmer P.B., and Bailey E. Transplacental exposure to genotoxins. Evaluation in haemoglobin of hydroxyethylvaline adduct levels in smoking and non-smoking mothers and their newborns. Carcinogenesis 15 (1994) 1271-1274
81. Törnqvist M., Gustafsson B., Kautiainen A., Harms-Ringdahl M., Granath F., and Ehrenberg L. Unsaturated lipids and intestinal bacteria as sources of endogenous production of ethene and ethylene oxide. Carcinogenesis 10 (1989) 39-41
82. Törnqvist M., and Landin H.H. Hemoglobin adducts for in vivo dose monitoring and cancer risk estimation. Journal of Occupational and Environmental Medicine 37 (1995) 1077-1085
83. Törnqvist M., Osterman-Golkar S., Kautiainen A., Jensen S., Farmer P.B., and Ehrenberg L. Tissue doses of ethylene oxide in cigarette smokers determined from adduct levels in hemoglobin. Carcinogenesis 7 (1986) 1519-1521
84. Törnqvist M., Osterman-Golkar S., Kautiainen A., Näslund M., Calleman C.J., and Ehrenberg L. Methylations in human hemoglobin. Mutation Research 204 (1988) 521-529
85. Törnqvist M., Svartengren M., and Ericsson C.H. Methylations in hemoglobin from monozygotic twins discordant for cigarette smoking: hereditary and tobacco-related factors. Chemico-Biological Interactions 82 (1992) 91-98
86. Tricker A.R. Nicotine metabolism, human drug metabolism polymorphisms, and smoking behaviour. Toxicology 183 (2003) 151-173
87. Tricker A.R., Ditrich C., and Preussmann R. N-Nitroso compounds in cigarette tobacco and their occurrence in mainstream tobacco smoke. Carcinogenesis 12 (1991) 257-261
88. US Department of Health and Human Services, 2001. Smoking and Tobacco Control. Risks Associated with Smoking Cigarettes with Low Machine-Measured Yields of Tar and Nicotine. Public Health Services, National Institutes of Health, National Cancer Institute (Eds.), NIH Publication, Bethesda, MD, USA.
89. Uchida K. Current status of acrolein as a lipid peroxidation product. Teratogenesis, Carcinogenesis, and Mutagenesis 9 (1999) 109-113
90. Ueda K., Kawachi I., Nakamura M., Nogami H., Shirokawa N., Masui S., Okayama A., and Oshima A. Cigarette nicotine yields and nicotine intake among Japanese male workers. Tobacco Control 11 (2002) 55-60
91. Van Rooij J.G.M., Veeger M.M.S., Bodelier-Bade M.M., Scheepers P.T.J., and Jongeneelen F.J. Smoking and dietary intake of polycyclic aromatic hydrocarbons as sources of interindividual variability in the baseline excretion of 1-hydroxypyrene in urine. International Archives of Occupational and Environmental Health 66 (1994) 55-65
92. van Sittert, N.J. 1996. N-2-Cyanoethyl-Valin, N-2-Hydroxyethyl-Valin, N-Methyl-Valin (zum Nachweis einer Belastung/Beanspruchung durch Acrylnitril, Ethylenoxid sowie methylierende Substanzen). In: Greim, H. (Ed.) Analytische Methoden zur Prüfung gesundheitsschädlicher Arbeitsstoffe. Analysen in biologischem Material. VCH Verlagsgesellschaft mbH, Weinheim, p. Bd 2 (12. Lieferung) 1-21.
93. van Welie R.T.H., van Dijck R.G.J.M., and Vermeulen N.P.E. Mercapturic acids, protein adducts, and DNA adducts as biomarkers of electrophilic chemicals. Critical Reviews in Toxicology 22 (1992) 271-306
94. Verband der Cigarettenindustrie, 2002. Cigarettenindustrie in Deutschland-Wirtschaftliche und demographische Daten.
95. Wynder E.L., and Hoffmann D. Tobacco and Tobacco Smoke (1967), Academic Press, New York, London